The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...

Already a monolith in the clinical testing space, Labcorp is aiming to further swell its testing capabilities with the acquisition of contract research organization Toxikon. The CRO provides ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, is making its LabCorp 2019 Novel Coronavirus (COVID-19 ...

BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp, a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid ...

BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...

The Food and Drug Administration gave the green light to Labcorp’s at-home combination test for Covid-19 and influenza A and B. The test kit received an emergency use authorization on Friday for ...

BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...